FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3905771 · Received July 1, 2014

Report

Report Number
2124215-2014-10979
Event Type
Malfunction
Date Received
July 1, 2014
Date of Event
January 31, 2014
Report Date
May 14, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. PIN GAUGE TESTING, DESIGNED TO VERIFY PROPER PORT DIMENSIONS, WAS COMPLETED. EACH PORT MEASURED AS EXPECTED. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE DEFIBRILLATION, PACING, AND SENSING FUNCTIONS WERE TESTED. IMPEDANCE TESTING WAS COMPLETED AND ALL MEASUREMENTS WERE WITHIN NORMAL LIMITS. THE DEVICE OPERATED APPROPRIATELY WITH NO INTERRUPTIONS IN THERAPY OUTPUT AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS SYSTEM HAD DISPLAYED MULTIPLE EVENS WITH NOISE ON THE RATE SENSE CHANNEL WHICH WAS BEING OVERSENSED. THERE WAS NOT NOISE OBSERVED DURING MANIPULATION OF THE DEVICE HEADER; HOWEVER, NOISE WAS RE-CREATED DURING ARM MOVEMENTS. IMPEDANCE MEASUREMENTS HAVE SLIGHTLY DECREASED SINCE IMPLANT AND THRESHOLD MEASUREMENTS HAVE SLIGHTLY INCREASED. IT WAS NOTED THAT THE DEVICE IS LOOSE IN THE POCKET AS WELL. A REVISION PROCEDURE WAS PERFORMED AND THIS DEVICE WAS EXPLANTED AND REPLACED WITHOUT FURTHER INCIDENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
383557 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 84 YR E102| 0185